Ming-Liang He

Title: The Innovative Contributions of Ming-Liang He

Introduction

Ming-Liang He is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of antiviral treatments, holding a total of 5 patents. His work focuses on developing innovative solutions for viral infections, particularly those associated with the SARS coronavirus.

Latest Patents

Ming-Liang He's latest patents include groundbreaking inventions such as PIM1 inhibitors for use in the treatment of viral infections. This patent describes a PIM1 proto-oncogene, serine/threonine kinase (PIM1) inhibitor that can be used in the preparation of a medicament for treating viral infections. The method involves administering an effective antiviral amount of a PIM1 inhibitor to a human afflicted with a viral infection. Another notable patent involves synthetic peptides targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection. This invention provides methods for locating critical portions of the spike protein (S protein) of SARS-CoV and offers new synthetic peptides for preventing or treating SARS-CoV infection in subjects.

Career Highlights

Ming-Liang He has worked at prestigious institutions such as The University of Hong Kong. His research has significantly advanced the understanding and treatment of viral infections, showcasing his dedication to improving public health through innovative solutions.

Collaborations

Ming-Liang He has collaborated with notable researchers, including Hsiang-Fu Kung and Yi Guan. These collaborations have further enriched his research and contributed to the development of effective antiviral therapies.

Conclusion

Ming-Liang He is a distinguished inventor whose work in antiviral treatments has made a lasting impact on the field. His innovative patents and collaborations reflect his commitment to advancing medical science and improving health outcomes.